ACR appropriateness criteria© ovarian cancer screening

Ultrasound Quarterly

Volumn 26, Issue 4, 2010, Pages 219-223

  Brown, Douglas L ^a   Andreotti, Rochelle F ^b   Lee, Susanna I ^c   Dejesus Allison, Sandra O ^d   Bennett, Genevieve L ^e   Dubinsky, Theodore ^f   Glanc, Phyllis ^g   Horrow, Mindy M ^h   Lev Toaff, Anna S ⁱ   Horowitz, Neil S ^j   Podrasky, Ann E ^k   Scoutt, Leslie M ^l   Zelop, Carolyn M ^m  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g WOMEN S COLLEGE HOSPITAL   (Canada)

^h ALBERT EINSTEIN MEDICAL CENTER   (United States)

ⁱ THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k BAPTIST HOSPITAL OF MIAMI   (United States)

^l YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

more..

Author keywords

Appropriateness criteria; Ovarian cancer; Screening; Ultrasound

Indexed keywords

CA 125 ANTIGEN;

ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE;

CA-125 ANTIGEN; FEMALE; HUMANS; MASS SCREENING; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY;

EID: 78650495441     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/RUQ.0b013e3181fdd604     Document Type: Article

References (26)

1. Clarke-Pearson DL. Clinical practice. Screening for ovarian cancer. N Engl J Med. 2009;361:170-177.
2. Bast RC Jr, Brewer M, Zou C, et al. Prevention and early detection of ovarian cancer: Mission impossible? Recent Results Cancer Res. 2007;174:91-100.
3. Stirling D, Evans DG, Pichert G, et al. Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system. J Clin Oncol. 2005;23:5588-5596.
4. Gaarenstroom KN, van der Hiel B, Tollenaar RA, et al. Efficacy of screening women at high risk of hereditary ovarian cancer: Results of an 11-year cohort study. Int J Gynecol Cancer. 2006;16(suppl 1):54-59.
5. Lacey JV Jr, Greene MH, Buys SS, et al. Ovarian cancer screening in women with a family history of breast or ovarian cancer. Obstet Gynecol. 2006;108:1176-1184.
6. Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index: Possibilities for earlier detection. Cancer. 2007;109:221-227.
7. Kurman RJ, Visvanathan K, Roden R, et al. Early detection and treatment of ovarian cancer: Shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 2008;198:351-356.
8. Yemelyanova AV, Cosin JA, Bidus MA, et al. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008;18:465-469.
9. Lee Y, Medeiros F, Kindelberger D, et al. Advances in the recognition of tubal intraepithelial carcinoma: Applications to cancer screening and the pathogenesis of ovarian cancer. Adv Anat Pathol. 2006;13:1-7.
10. Levine D, Gosink BB, Wolf SI, et al. Simple adnexal cysts: The natural history in postmenopausal women. Radiology. 1992;184:653-659.
11. Taylor KJ, Schwartz PE. Screening for early ovarian cancer. Radiology. 1994;192:1-10.
12. Walsh CS, Karlan BY. Contemporary progress in ovarian cancer screening. Curr Oncol Rep. 2007;9:485-493.
13. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572-577.
14. Campbell S, Bhan V, Royston P, et al. Transabdominal ultrasound screening for early ovarian cancer. BMJ. 1989;299:1363-1367.
15. van Nagell JR Jr, DePriest PD, Ueland FR, et al. Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened. Cancer. 2007;109:1887-1896.
16. Fishman DA, Cohen L, Blank SV, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005;192:1214-1221; discussion 1221-1222.
17. Van Nagell JR Jr, DePriest PD, Puls LE, et al. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Cancer. 1991;68:458-462.
18. Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009;10:327-340.
19. Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A. Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: A systematic review. Br J Radiol. 2008;81:172-179.
20. Evans DG, Gaarenstroom KN, Stirling D, et al. Screening for familial ovarian cancer: Poor survival of BRCA1/2 related cancers. J Med Genet. 2009;46:593-597.
21. Kinkel K, Hricak H, Lu Y, et al. US characterization of ovarian masses: A meta-analysis. Radiology. 2000;217:803-811.
22. Alcazar JL. New Ultrasound-Based Technologies for Predicting Ovarian Cancer in Adnexal Masses Current Women's Health Reviews. Curr Wom Health Rev. 2007; 3:89-94.
23. Fleischer AC, Lyshchik A, Jones HW 3rd, et al. Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography. J Ultrasound Med. 2009;28:1273-1280.
24. Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004;3:355-366.
25. Tailor A, Bourne TH, Campbell S, et al. Results from an ultrasound-based familial ovarian cancer screening clinic: A 10-year observational study. Ultrasound Obstet Gynecol. 2003;21:378-385.
26. American Colllege of Radiology. ACR Appropriateness Criteria®: Radiation dose assessment introduction. Available at: Http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/app-criteria/RRLInformation.aspx. Accessed Sept. 10, 2010.